HTA Programmer (SAS/R) for AMNOG & HEOR — Remote

Devoteam Spain; Madrid; Hybrid; EUR 42,000 - 66,000; Full time

Job summary

IQVIA is seeking an HTA Programmer with SAS and R expertise to support German AMNOG dossiers from Madrid. You will apply statistical programming to clinical data and collaborate with cross-functional teams to drive market access decisions.

The role targets biostatisticians or data scientists with a strong interest in HTA, AMNOG, and HEOR. It is based in Madrid with remote/hybrid flexibility and a focus on robust, audit-ready analyses.

Qualifications

• Master's degree or PhD in biostatistics, data science, or related field.
• Initial experience in HTA, AMNOG, HEOR, or Market Access and/or clinical development.
• Solid understanding of clinical study designs and statistical principles.
• Familiarity with clinical study data and CDISC SDTM/ADaM standards.

Responsibilities

• Contribute to development of German AMNOG dossiers, focusing on statistical analyses for Module 4.
• Perform analysis of clinical trial data including efficacy, safety, and subgroups.
• Conduct meta-analyses and indirect treatment comparisons; support interpretation of results.
• Automate and standardize analysis workflows for efficiency and reproducibility.
• Collaborate with Market Access, HEOR, Medical Affairs, and EU-HTA teams.
• Ensure scientific quality, clarity, and consistency of outcomes.

Skills

SAS programming

R programming

HTA/AMNOG knowledge

CDISC SDTM/ADaM

statistical analysis

data analysis

automation of workflows

team collaboration

Education

Master's degree or PhD in biostatistics or data science

Tools

SAS

R

Job description

IQVIA is seeking an HTA Programmer with SAS and R expertise to support German AMNOG dossiers from Madrid. You will apply statistical programming to clinical data and collaborate with cross-functional teams to drive market access decisions.

The role targets biostatisticians or data scientists with a strong interest in HTA, AMNOG, and HEOR. It is based in Madrid with remote/hybrid flexibility and a focus on robust, audit-ready analyses.